Asian Implantable Drug Delivery Devices Market Research Report
- Report Code: IM 1003
- Publish Date: Upcoming
The Asian Implantable Drug Delivery Market, mainly driven by a growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population was valued at $1.6 billion in 2013 and expected to be $2.4 billion by 2018, growing at a CAGR of 8.8%.
The report “Asian Implantable Drug Delivery Market forecast, 2012-2018 “analyzes the market of devices by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.
The pharmaceutical markets in India and China are growing rapidly owing to low costs and favorable regulatory environments. The Indian pharmaceutical market was ranked 4th in terms of volume and 15th in terms of value in 2011, and is expected to reach $20 billion by 2015. The Chinese pharmaceutical market was ranked third largest (by value) with size worth $64 billion and is expected to become the second largest by 2015, growing at more than 20% annually.
Asia held a share of 15.0% of the total drug delivery market in 2012 and was worth $21.71 billion. It is poised to grow at a double-digit CAGR of 12.6%, to reach $39.35 billion by 2017. The major factors propelling the Asian market are saturated Western markets and economic downturn in the U.S. and Europe. Furthermore, expansion of the Asian economy, increase in disposable income, development of healthcare infrastructure, increasing penetration of health insurance, and rising prevalence of chronic diseases will drive the growth of the pharmaceutical market. This, in turn, will accelerate the growth of the drug delivery market in Asia.
The report also provides an extensive competitive landscaping of companies operating in Implantable Drug Delivery market. The main companies operating in Implantable Drug Delivery Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of Implantable Drug Delivery products (Segment wise)
- Product Matrix which gives a detailed comparison of Implantable Drug Delivery product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of Prostate Cancer, Breast and female genital organs Cancers, Lung and pleura Cancers, Head and neck cancers, Colorectal Cancer, Spine Cancer and Brain Cancer
- Country specific Patient pool of Prostate Cancer, Breast and female genital organs Cancers, Lung and pleura Cancers, Head and neck cancers, Colorectal Cancer, Spine Cancer and Brain Cancer
- Disease progression (Pattern analysis)
Pharmacists Forum
- Fast turn-around analysis of Pharmacists response to market events and trends
- Pharmacists opinion about Implantable Drug Delivery products from different companies
- Pharmacists qualitative inputs on epidemiology data
- Pattern analysis of usage of drugs by physicians
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost Analysis of Drug Delivery Implants in Various Countries.
- Prostate Cancer, diabetic retinopathy, Colorectal Cancer, cardiovascular implants procedural investment in major countries.
Competitive Intelligence
- The company share analysis of Implantable Drug Delivery Systems for the top players of the market in the Asia.
- The crucial developments and strategies of companies inculcating in their portfolio for Implantable Drug Delivery Systems.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Drug Delivery Devices Market The North American Drug Delivery Devices Market was valued at $16 billion in 2013 and expected to be $110 billion by 2018, growing at a CAGR of 8.9%. The report “North American Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in Drug Delivery Devices market and extensively covered in this report are SkyePharma Plc (U.K.), Ypsomed Holding AG (Switzerland), and GSK (U.K.). |
Upcoming |
|
|
European Drug Delivery Devices Market The European Drug Delivery Devices Market was valued at $45 billion in 2013 and expected to be $63 billion by 2018, growing at a CAGR of 8.3%. The report “European Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in Drug Delivery Devices market and extensively covered in this report are SkyePharma Plc (U.K.), Ypsomed Holding AG (Switzerland), and GSK (U.K.). |
Upcoming |
|
|
Asian Drug Delivery Devices Market The Asian Drug Delivery Devices Market was valued at $28 billion in 2013 and expected to be $50 billion by 2018, growing at a CAGR of 12.6%. The report “Asian Drug Delivery Devices Market Forecast, 2012-2018“analyzes the market of Drug Delivery Devices by 9 technologies such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular and topical drug delivery devices. The main companies operating in this market and extensively covered in this report are 3M Company, Alkermes, Baxter International, Inc., Becton, Dickinson & Co., The Dow Chemical Company, Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC,. |
Upcoming |
